RESMED INC — Director's Dealing 2017

Nov 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-06

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-06	ResMed Common Stock	M	20000	$27.58	Acquired	314800	Direct
2017-11-06	ResMed Common Stock	S	18000	$83.497	Disposed	296800	Direct
2017-11-06	ResMed Common Stock	S	2000	$83.817	Disposed	294800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-06	Resmed Stock Option Plan	$27.58	M	20000	Disposed	2018-11-16	ResMed Common Stock (20000)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from 82.75 to 83.75. The price reported above represents the weighted average sales price.

F3: This transaction was executed in multiple trades at prices ranging from $83.76 to $83.93. The price reported above reflects the weighted average sale price.

F4: Represents date options first became exercisable. Options vested 1/4 per year.